The following information is obtained from various newswires,
published medical journal articles, and medical conference presentations.
Company: Aventis Pasteur
Approval Status: Approved September 2002
Treatment for: Influenza immunization in infants
General Information
The preservative-free formulation of the Fluzone Influenza Virus Vaccine was approved in September 2002 to immunize high-risk and normal infants, aged six months to 35 months.
Fluzone is also available in its non-preservative-free formulation for pediatric and adult patients.
Additional Information
For further information about Fluzone, visit the Aventis Pasteur vaccine product web site at www.vaccineshoppe.com.
